NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment

Clinical trial NCT02239003 · COMPLETED

Trial details

NCT number: NCT02239003
Sponsor: Chang Gung Memorial Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment

Start date: 2012-01-01
Primary completion: 2017-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.